Bethany Young Holt, PhD, MPH
Dr. Bethany Young Holt is the Director and Co-Founder of the IMPT (Initiative for Multipurpose Prevention Technologies), the Executive Director of CAMI Health, and a Principal Investigator (PI) at the Public Health Institute.
Dr. Holt’s background is in sexual and reproductive health epidemiology and prevention in the U.S. and in Africa, including multi-level analyses, social determinants of health, microbicide acceptability studies, and market research. As the PI or co-investigator on a range of studies, she has collaborated with multidisciplinary teams of researchers, including clinicians, product developers, socio-behavioral and market researchers, mechanical engineers, as well as advocates and community groups.
As the Executive Director of CAMI Health, Dr. Holt has engineered the first Collective Impact Collaboration that bridges HIV, STI and family planning research and development fields to create a new arena for comprehensive prevention.
Dr. Holt’s over 25 years of work in the areas of reproductive health and HIV/STI prevention in the U.S. and internationally includes traineeships at the National Cancer Institute, the Centers for Disease Control and Prevention, and the Institute Pasteur in Dakar, Senegal; anthropological field work in the Samoan Islands, and Peace Corps volunteer and relief work with the U.N. High Commission for Refugees (UNHCR) in Mauritania, Senegal and Ethiopia.
Advancing the Development and Availability of MPT Products for Those at Highest Unmet Need Around the Globe
This CAMI project seeks to advance the development and availability of multipurpose prevention technology (MPT) products that simultaneously address the need to prevent unintended pregnancy, HIV and other sexually transmitted infections in high-risk regions of the world. It will identify and respond to MPT scientific priority issues and gaps and help coordinate the major MPT supporting organizations to optimize current resources and efforts as well as to mobilize new resources to expand multisectoral support and investment in MPTs.
Developing and Introducing Multipurpose Prevention Technologies for Women and Girls
This multi-year project headed by CAMI Health will advance and develop the introduction of Multipurpose Prevention Technologies (MPTs) for women and girls who have the highest unmet needs. The objective is to accelerate action around priority challenges and gaps in the MPT field.
Health Literacy around MPTs and Simultaneous Prevention of Unintended Pregnancies and STIs
CAMI has developed outreach materials to raise awareness about the simultaneous risk of unintended pregnancy and STIs, and the need for MPTs. Examples include:
- Global Reproductive Health Diaries: Development and distribution of educational and advocacy materials.
- Sister to Sister Photo novellas: We are currently seeking support to expand these novellas in different regions using mHealth.
Initiative for Multipurpose Prevention Technologies (IMPT)
CAMI serves as the Secretariat for the IMPT. Since 2009, CAMI and our IMPT partners have built upon over two decades of work on dual-protection and address the intrinsic link between unintended pregnancy and risk for HIV and other sexually transmitted infections.
Product Development and Access to Multipurpose Prevention Technologies
CAMI Health continues to serve as the Initiative for Multipurpose Prevention Technologies secretariat with efforts to advance the development and support of Multipurpose Prevention Technologies (MPT) with a focus on contraceptive MPTs in alignment with NICHD priorities. This will be accomplished by enhancing collaborative partnerships through regular information exchange between stakeholders as well as through scientific and technical activities including convenings around priority issues and advocacy.
Supporting CAMI Health
This project is to advance the MPT scientific agenda and facilitate coordination and collaboration among key partners to enhance support for the field: 1) Assess feasibility of expanding the MPT Product Pipeline Database to include work in China and Russia; 2) Landscape analysis of MPT-related projects and activities internationally; and 3) Development and production of support materials critical in MPT activities for CAMI and IMPT members in the US and across the globe.
Transforming Contraception to Expand Access and Choice
Letter of Authorization to develop a full scope of work and budget for first year of the project. Continues CAMI’s work with USAID which was formally funded through PATH.